3-Nitrosobenzamide
Alternative Names: NOBA; NSC 674195Latest Information Update: 29 Jul 1998
Price :
$50 *
At a glance
- Originator National Cancer Institute (USA)
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 29 Jul 1998 No-Development-Reported for HIV-1 infections in USA (Unknown route)